Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (2097)	7/22/1998 3:21:00 PM
From: IN_GOD_I_TRUST	Respond to of 4676

This is breakthrough approval for the technology...I think that's what is important... Steve

To: jopawa who wrote (2097)	7/22/1998 3:26:00 PM
From: Mailbu	Read Replies (2) \| Respond to of 4676

I think there are a lot of skeptics out there. A lot of people betting against ISIP. If you read the Bloomberg report for this morning about ISIP they painted a somewhat negative outlook. I think this will add some credibility to ISIP and hopefully attract more coverage. Just my opinion, we will see soon.

To: jopawa who wrote (2097)	7/22/1998 3:34:00 PM
From: DTselentis	Read Replies (1) \| Respond to of 4676

I don't think the recomendation is priced into the stock. The last few days heavy accumulation of the stock has just started according to IBD- the stock traded higher- 20 or so a few years back with no drugs nearing approval. The validation of antisense technology if approval is granted should give the stock a nice boost.